[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349631-105":59,"doc-detail-349631-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pervasive-tissue-specificity-of-driver-genes-revealed-by-mutational-analysis-of-265-cancer-types","Pervasive tissue specificity of driver genes revealed by mutational analysis of 265 cancer types","","The study addresses how traditional cancer driver gene definitions can miss genes enriched in rarer tumor subtypes due to pooling across histologies. A statistical framework is introduced to quantify, for each gene, incidence and tissue specificity based on functional somatic mutations in primary cancers. Applied to the AACR GENIE v18.0 dataset, the framework finds 165 significantly mutated genes across at least one subtype. Tissue specificity is shown to be the norm, with restricted-expression oncogenes displaying distinct tumor tissue mutation patterns, supporting resources for cancer genetics and clinical oncology.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pervasive-tissue-specificity-of-driver-genes-revealed-by-mutational-analysis-of-265-cancer-types/349631/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pervasive-tissue-specificity-of-driver-genes-revealed-by-mutational-analysis-of-265-cancer-types/349631.png","ImageObject",300,407,{"name":92,"@type":93},"CatatanPagi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in defining cancer driver genes?","Question",{"text":112,"@type":113},"Traditional driver definitions often pool mutations across common cancer types, creating a bias toward well-represented histologies and reducing power for rarer subtypes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the proposed framework quantify tissue specificity for driver genes?",{"text":117,"@type":113},"It evaluates enrichment of functional somatic mutations within each histologic subtype to quantify incidence and tissue specificity per gene.",{"name":119,"@type":110,"acceptedAnswer":120},"What are the key findings when the framework is applied to the AACR GENIE v18.0 dataset?",{"text":121,"@type":113},"The analysis identifies 165 genes significantly mutated in at least one subtype and shows that tissue specificity is the norm rather than an exception, including higher tissue-specific mutation patterns for some oncogenes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349631,1790951957,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","iScience Article  \nPervasive tissue specificity of driver genes revealed by mutational analysis of 265 cancer types  \nGraphical abstract  \nHighlights  \n• We present a new tissue specificity score to quantify this property for 165 genes  \nAuthors  \nJiayi Chen, Ryan L. Collins, Kevin M. Haigis  \nCorrespondence  \n[ryan_collins@dfci.harvard.edu](ryan_collins@dfci.harvard.edu) (R.L.C.),  \n[kevin_haigis@dfci.harvard.edu](kevin_haigis@dfci.harvard.edu) (K.M.H.)  \nIn brief  \nBioinformatics; Cancer  \n• Tissue specificity of cancer driver genes is the norm, with few exceptions like TP53  \n• Gene expression in normal tissues partly explains tissue specificity of oncogenes  \n• Functional redundancy in key pathways influence tumor suppressor tissue specificity  \nChen et al., 2026, iScience 29, 117272  \nSeptember 18, 2026 © 2026 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.isci.2026.117272](https://doi.org/10.1016/j.isci.2026.117272)  \nll  \niScience  \nll  \nOPEN ACCESS  \nArticle  \nPervasive tissue specificity of driver genes revealed by mutational analysis  \nof 265 cancer types  \nJiayi Chen,1,2,3 Ryan L. Collins,3,4,5,* and Kevin M. Haigis2,3,5,6,*  \n1Departments of Biostatistics and Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA  \n2Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA  \n3Cancer Program, Broad Institute of M. I.T. and Harvard, Cambridge, MA, USA  \n4Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA  \n5Department of Medicine, Harvard Medical School, Boston, MA, USA  \n6Lead contact  \n*Correspondence: [ryan_collins@dfci.harvard.edu](ryan_collins@dfci.harvard.edu) (R. L.C.), [kevin_haigis@dfci.harvard.edu](kevin_haigis@dfci.harvard.edu) (K. M. H.) [https://doi.org/10.1016/j.isci.2026.117272](https://doi.org/10.1016/j.isci.2026.117272)  \nSUMMARY  \nDefining genes that are somatically mutated in different cancer types is a central goal of cancer genetics. Nevertheless, traditional definitions of ‘‘driver’’ genes are biased toward common cancer types and tend to overlook genes that might be specific to rarer subtypes. We developed a statistical framework that defines genes enriched for functional somatic mutations in primary cancers to quantify incidence and tissue specificity for each gene. By applying this framework to the AACR GENIE v18.0 dataset, we identified 165 genes significantly mutated in at least one subtype. We mined this dataset to derive tissue specificity scores for all 165 genes, demonstrating that tissue specificity is the norm, not the exception. We also found that oncogenes with restricted expression across normal tissues tend to exhibit higher tissue-specific mutation patterns in cancer. We anticipate that the resources developed in this study will be useful for cancer research and clinical oncology.  \nINTRODUCTION  \nIdentifying cancer driver genes, defined as genes wherein somatic alterations confer a selective growth advantage to tumor cells, is fundamental to understanding tumor biology and guiding therapeutic development. Large-scale efforts such as The Cancer Genome Atlas (TCGA) have profiled thousands of tumors with a variety of genomic technologies, and many sophisticated methods have been proposed for nominating mutational driver genes.1 ,2 As a general rule, most approaches typically definedriver genes based on mutational recurrence across a pooled set of tumor samples grouped by histology or tissue-of-origin.3 However, this pooled approach introduces a key limitation: genes that are commonly mutated in the common cancer types that are well represented in these studies, such as lung or breast cancer, tend to dominate the resulting lists of cancer driver genes. This bias is driven by relatively modest sample sizes for less common cancers in most pan-cancer cohorts, leading to low statistical power and a high false negative rate for driver gene detection in rarer cancers. As a result, genes that play imp","cbCaiaV8Wsoz5Xrb","https://ap.wps.com/l/cbCaiaV8Wsoz5Xrb","pdf",7260788,"English","# Highlights\n## Tissue specificity in driver genes\n# Summary\n# Introduction\n## Limitations of pooled driver gene definitions\n## Evidence that tissue specificity is common\n## New opportunities with expanded pan-cancer resources","[{\"question\":\"What problem does the study address in defining cancer driver genes?\",\"answer\":\"Traditional driver definitions often pool mutations across common cancer types, creating a bias toward well-represented histologies and reducing power for rarer subtypes.\"},{\"question\":\"How does the proposed framework quantify tissue specificity for driver genes?\",\"answer\":\"It evaluates enrichment of functional somatic mutations within each histologic subtype to quantify incidence and tissue specificity per gene.\"},{\"question\":\"What are the key findings when the framework is applied to the AACR GENIE v18.0 dataset?\",\"answer\":\"The analysis identifies 165 genes significantly mutated in at least one subtype and shows that tissue specificity is the norm rather than an exception, including higher tissue-specific mutation patterns for some oncogenes.\"}]","Pervasive tissue specificity of driver genes revealed by mutational analysis of 265 cancer types | PDF",1790084598,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d73ffa75485944a241f43f4683f275c.webp",983,1276,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bdcea17b565c36a480d1b1c1d8328e95.webp",982,1275,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff80255e9c9490d8524839b446af9ef8.webp",981,1273,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdd9b38696ffc368fb6e86ab963126b1.webp",980,1272]